NeuroSense Announces Year End 2023 Financial Results and Pro

CAMBRIDGE, Mass., April 5, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. , a company developing novel treatments for severe neurodegenerative diseases, today reported its financial results for...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , , Exchange Commission , Drug Administration , Nasdaq , Neurosense Therapeutics Ltd , European Medicines Agency , Prnewswire Neurosense Therapeutics Ltd , Exchange Commission On , Sense Therapeutics , Per Protocol , Orphan Drug Designation , European Medicines , Neurosense Therapeutic , Annual Report , Neurosense Therapeutics , Markets ,